WAVE LIFE SCIENCES LTD. Operating Lease, Weighted Average Discount Rate, Percent
WAVE LIFE SCIENCES LTD. (WVE) had Operating Lease, Weighted Average Discount Rate, Percent of 9.30% as of 2025-12-31, per its 10-K filed 2026-02-26.
Financial Statements › Notes › Leases
us-gaap:OperatingLeaseWeightedAverageDiscountRatePercent · last filed 2026-02-26
- 2025-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.30%.
- 2024-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
- 2023-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
- 2022-12-31: Operating Lease, Weighted Average Discount Rate, Percent 9.20%.
| Period end | Operating Lease, Weighted Average Discount Rate, Percent |
|---|---|
| 2025-12-31 | 9.30% 10-K · filed 2026-02-26 |
| 2024-12-31 | 9.20% 10-K · filed 2026-02-26 |
| 2023-12-31 | 9.20% 10-K · filed 2026-02-26 |
| 2022-12-31 | 9.20% 10-K · filed 2025-03-04 |
| 2021-12-31 | 8.40% 10-K · filed 2023-03-23 |
| 2020-12-31 | 8.50% 10-K · filed 2022-03-03 |
| 2019-12-31 | 8.50% 10-K · filed 2021-03-04 |
| 2019-09-30 | 8.50% 10-Q · filed 2019-11-05 |
| 2019-06-30 | 8.50% 10-Q · filed 2019-08-06 |
| 2019-03-31 | 8.50% 10-Q · filed 2019-05-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Olema Pharmaceuticals, Inc. (OLMA) | United States | $0.790B | -5.35 |
| Aclaris Therapeutics, Inc. (ACRS) | United States | $0.792B | -9.78 |
| Design Therapeutics, Inc. (DSGN) | United States | $0.766B | -12.78 |
| GERON CORP (GERN) | United States | $0.803B | -12.14 |
| Faeth Therapeutics, Inc. (FTH) | United States | $0.750B | |
| GYRE THERAPEUTICS, INC. (GYRE) | United States | $0.818B | -24.71 |
| LEXICON PHARMACEUTICALS, INC. (LXRX) | United States | $0.823B | -17.48 |
| COLLEGIUM PHARMACEUTICAL, INC (COLL) | United States | $0.737B | 24.57 |
| Obsidian Therapeutics, Inc. (OBX) | United States | $0.829B | |
| Immix Biopharma, Inc. (IMMX) | United States | $0.837B | -18.44 |